BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 31161939)

  • 1. What Have We Learned from Studies of IFN-λ Variants and Hepatitis C Virus Infection?
    O'Brien TR; Jackson SS
    J Interferon Cytokine Res; 2019 Oct; 39(10):618-626. PubMed ID: 31161939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of functional variants in IFNL4 and IFNL3 for association with HCV clearance.
    O'Brien TR; Pfeiffer RM; Paquin A; Lang Kuhs KA; Chen S; Bonkovsky HL; Edlin BR; Howell CD; Kirk GD; Kuniholm MH; Morgan TR; Strickler HD; Thomas DL; Prokunina-Olsson L
    J Hepatol; 2015 Nov; 63(5):1103-10. PubMed ID: 26186989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Confounding by Single Nucleotide Polymorphism rs117648444 (P70S) Affects the Association of Interferon Lambda Locus Variants with Response to Interferon-α-Ribavirin Therapy in Patients with Chronic Genotype 3 Hepatitis C Virus Infection.
    Bhushan A; Ghosh S; Bhattacharjee S; Chinnaswamy S
    J Interferon Cytokine Res; 2017 Aug; 37(8):369-382. PubMed ID: 28727946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymorphism rs368234815 of interferon lambda 4 gene and spontaneous clearance of hepatitis C virus in haemodialysis patients: a case-control study.
    Grzegorzewska AE; Mostowska A; Świderska MK; Marcinkowski W; Stolarek I; Figlerowicz M; Jagodziński PP
    BMC Infect Dis; 2021 Jan; 21(1):102. PubMed ID: 33482747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intracellular Accumulation of IFN-λ4 Induces ER Stress and Results in Anti-Cirrhotic but Pro-HCV Effects.
    Onabajo OO; Wang F; Lee MH; Florez-Vargas O; Obajemu A; Tanikawa C; Vargas JM; Liao SF; Song C; Huang YH; Shen CY; Banday AR; O'Brien TR; Hu Z; Matsuda K; Prokunina-Olsson L
    Front Immunol; 2021; 12():692263. PubMed ID: 34497603
    [No Abstract]   [Full Text] [Related]  

  • 6. Absence of interferon-λ 4 enhances spontaneous clearance of acute hepatitis C virus genotypes 1-3 infection.
    Waldenström J; Kåberg M; Alanko Blomé M; Widell A; Björkman P; Nilsson S; Hammarberg A; Weiland O; Nyström K; Lagging M
    Scand J Gastroenterol; 2021 Jul; 56(7):855-861. PubMed ID: 34034600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IFN-λ4: the paradoxical new member of the interferon lambda family.
    O'Brien TR; Prokunina-Olsson L; Donnelly RP
    J Interferon Cytokine Res; 2014 Nov; 34(11):829-38. PubMed ID: 24786669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paraoxonase 1 gene (PON1) variants concerning hepatitis C virus (HCV) spontaneous clearance in hemodialysis individuals: a case-control study.
    Grzegorzewska AE; Mostowska A; Warchoł W; Jagodziński PP
    BMC Infect Dis; 2021 Aug; 21(1):875. PubMed ID: 34445971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IFNL4: Notable variants and associated phenotypes
    Fang MZ; Jackson SS; O'Brien TR
    Gene; 2020 Mar; 730():144289. PubMed ID: 31846709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The IFN-λ4 Conundrum: When a Good Interferon Goes Bad.
    Onabajo OO; Muchmore B; Prokunina-Olsson L
    J Interferon Cytokine Res; 2019 Oct; 39(10):636-641. PubMed ID: 31241411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interferon-λ4 (IFNL4) transcript expression in human liver tissue samples.
    Amanzada A; Kopp W; Spengler U; Ramadori G; Mihm S
    PLoS One; 2013; 8(12):e84026. PubMed ID: 24376784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon-λ4 is a cell-autonomous type III interferon associated with pre-treatment hepatitis C virus burden.
    Lu YF; Goldstein DB; Urban TJ; Bradrick SS
    Virology; 2015 Feb; 476():334-340. PubMed ID: 25577150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IFN-λ4 genetic variants influence clinical malaria episodes in a cohort of Kenyan children.
    Samayoa-Reyes G; Jackson C; Ogolla S; Sabourin K; Obajemu A; Dent AE; Prokunina-Olsson L; Rochford R
    Malar J; 2021 Apr; 20(1):196. PubMed ID: 33882912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic IFNL4 expression is associated with non-response to interferon-based therapy through the regulation of basal interferon-stimulated gene expression in chronic hepatitis C patients.
    Murakawa M; Asahina Y; Kawai-Kitahata F; Nakagawa M; Nitta S; Otani S; Nagata H; Kaneko S; Asano Y; Tsunoda T; Miyoshi M; Itsui Y; Azuma S; Kakinuma S; Tanaka Y; Iijima S; Tsuchiya K; Izumi N; Tohda S; Watanabe M
    J Med Virol; 2017 Jul; 89(7):1241-1247. PubMed ID: 28036111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Novel Inactive Isoform with a Restored Reading Frame Is Expressed from the Human Interferon Lambda 4 TT Allele at rs368234815.
    Bharatiya S; Agarwal A; Chinnaswamy S
    J Interferon Cytokine Res; 2023 Sep; 43(9):370-378. PubMed ID: 36880961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic Interferon-λ3 (IFNL3) Gene Expression Reveals Not to Be Attenuated in Non-Favorable IFNL3 rs4803217 or IFNL4 rs368234815 Minor Allele Carriers in Chronic Hepatitis C.
    Amanzada A; Reinhardt L; Fey D; Zeisberg EM; Mihm S
    PLoS One; 2015; 10(11):e0143783. PubMed ID: 26606750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic Polymorphisms within Interferon-λ Region and Interferon-λ3 in the Human Pathophysiology: Their Contribution to Outcome, Treatment, and Prevention of Infections with Hepatotropic Viruses.
    Grzegorzewska AE
    Curr Med Chem; 2019; 26(25):4832-4851. PubMed ID: 30027841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Presence of interferon-λ 4, male gender, absent/mild steatosis and low viral load augment antibody levels to hepatitis C virus.
    Waldenström J; Hellstrand K; Westin J; Nilsson S; Christensen P; Färkkilä M; Mørch K; Langeland N; Norkrans G; Lagging M
    Scand J Gastroenterol; 2021 Jul; 56(7):849-854. PubMed ID: 34078234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferon-λ rs12979860 genotype association with liver fibrosis in chronic hepatitis C (CHC) patients in the Pakistani population.
    Rauff B; Amar A; Chudhary SA; Mahmood S; Tayyab GUN; Hanif R
    Arch Virol; 2021 Apr; 166(4):1047-1056. PubMed ID: 33528661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon-lambda4 genetic polymorphism is associated with the therapy response for hepatitis C virus recurrence after a living donor liver transplant.
    Konishi H; Motomura T; Matsumoto Y; Harimoto N; Ikegami T; Yoshizumi T; Soejima Y; Shirabe K; Fukuhara T; Maehara Y
    J Viral Hepat; 2014 Jun; 21(6):397-404. PubMed ID: 24750545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.